Pharmacists in Martinez, California


158 Pharmacists found in Martinez
female pharmacist

Tiffany Ho, PHARMD


Pharmacist
200 Muir Rd, Martinez, CA 94553
408-598-0507    

female pharmacist

Dr. Tracy Hsu, PHARM.D.


Pharmacist
150 Muir Road, Martinez, CA 94553
925-372-2167    

female pharmacist

Tracy Elizabeth Phan, PHARM.D.


Pharmacist
2500 Alhambra Ave, Martinez, CA 94553
925-370-5668    



male pharmacist

Dr. Trevor Millington, PHARM.D.


Pharmacist
200 Muir Rd, Martinez, CA 94553
626-321-2963    

female pharmacist

Trupti Atul Shah


Pharmacist
1165 Arnold Dr, Martinez, CA 94553
925-372-0945     925-372-6516

female pharmacist

Mrs. Tuyet Jennifer Vuong, PHARMACIST


Pharmacist
150 Muir Rd, Martinez, CA 94553
925-372-2380    

male pharmacist

Ut Nguyen


Pharmacist
400 Muir Rd, Martinez, CA 94553
925-313-4544     925-372-1714

female pharmacist

Miss Uyen Do


Pharmacist
200 Muir Rd, Martinez, CA 94553
925-313-4544    

female pharmacist

Vivian Sandy, PHARM.D.


Pharmacist
200 Muir Rd, Martinez, CA 94553
925-372-1221    

male pharmacist

Dr. William Ofstad, PHARMD


Pharmacist
200 Muir Rd, Martinez, CA 94553
626-644-7421    

male pharmacist

Dr. Xifan Ge, PHARMD


Pharmacist
200 Muir Rd, Martinez, CA 94553
760-683-4919    

male pharmacist

Dr. Yama F Saied, PHARM. D


Pharmacist
1021 Arnold Dr, Martinez, CA 94553
925-313-9059     925-313-9428

female pharmacist

Yolanda True, RPH


Pharmacist
200 Muir Rd, Martinez, CA 94553
925-313-4051    

female pharmacist

Dr. Yue Liu, PHARM.D.


Pharmacist
200 Muir Rd, H1c50, Martinez, CA 94553
925-313-4554     925-372-1229


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.